Cargando…

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma

Effective treatment of glioblastoma (GBM) remains an open challenge. Given the critical role of the immune microenvironment in the progression of cancers, we aimed to develop an immune-related gene (IRG) signature for predicting prognosis and improving the current treatment paradigm of GBM. Multi-om...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Hang, Zhao, Hongtao, Jin, Jiaqi, Liu, Zhihui, Gao, Xin, Wang, Fang, Dong, Jiawei, Yan, Xiuwei, Zhang, Jiheng, Wang, Nan, Du, Jianyang, Hu, Shaoshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801921/ https://www.ncbi.nlm.nih.gov/pubmed/35111196 http://dx.doi.org/10.3389/fgene.2021.736187

Ejemplares similares

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
por: Ji, Hang, et al.
Publicado: (2021)

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme
por: Dong, Jiawei, et al.
Publicado: (2022)

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
por: Wang, Nan, et al.
Publicado: (2022)

Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma
por: Zhao, Hongtao, et al.
Publicado: (2023)

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas
por: Ji, Hang, et al.
Publicado: (2022)

Rapid progression of subcutaneous glioblastoma: A case report and literature review
por: Wang, Fang, et al.
Publicado: (2023)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
por: Wu, Jiasheng, et al.
Publicado: (2022)

Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism
por: Liu, Zhihui, et al.
Publicado: (2022)

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma
por: Liu, Zhihui, et al.
Publicado: (2022)

Using mixed reality technique combines multimodal imaging signatures to adjuvant glioma photodynamic therapy
por: Dong, Jiawei, et al.
Publicado: (2023)

Extended Application of Genomic Selection to Screen Multi-Omics Data for the Development of Novel Pyroptosis-Immune Signatures and Predicting Immunotherapy of Glioma
por: Ma, Shuai, et al.
Publicado: (2022)

CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
por: Wang, Fang, et al.
Publicado: (2022)

Pituitary adenoma secondary to primary hypothyroidism: Two case reports
por: Du, Jianyang, et al.
Publicado: (2020)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
por: Tao, Sifan, et al.
Publicado: (2022)

A Potential Indicator ARRDC2 Has Feasibility to Evaluate Prognosis and Immune Microenvironment in Ovarian Cancer
por: Zhang, Mengjun, et al.
Publicado: (2022)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

The cuproptosis-related signature predicts prognosis and indicates immune microenvironment in breast cancer
por: Li, Jia, et al.
Publicado: (2022)

Corrigendum: A potential indicator ARRDC2 has feasibility to evaluate prognosis and immune microenvironment in ovarian cancer
por: Zhang, Mengjun, et al.
Publicado: (2022)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

A circadian rhythm-related gene signature for prognosis, invasion and immune microenvironment of breast cancer
por: Wang, Mei-Huan, et al.
Publicado: (2023)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
por: Song, Binyu, et al.
Publicado: (2022)

Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma
por: Zou, Xiaoli, et al.
Publicado: (2022)

TGFβ-Associated Signature Predicts Prognosis and Tumor Microenvironment Infiltration Characterization in Gastric Carcinoma
por: Liu, Siyuan, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Novel Stemness-Related Gene Signature Predicting Prognosis and Indicating a Different Immune Microenvironment in HNSCC
por: Luo, Yi, et al.
Publicado: (2022)

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
por: Wang, Guowei, et al.
Publicado: (2022)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

A Wnt-related gene expression signature to improve the prediction of prognosis and tumor microenvironment in gastric cancer
por: Kong, Shuai, et al.
Publicado: (2022)

Novel Hypoxia-Associated Gene Signature Depicts Tumor Immune Microenvironment and Predicts Prognosis of Colon Cancer Patients
por: Xu, Yixin, et al.
Publicado: (2022)

A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma
por: Fang, Xueying, et al.
Publicado: (2022)

TP53-related signature for predicting prognosis and tumor microenvironment characteristics in bladder cancer: A multi-omics study
por: Tao, Yuting, et al.
Publicado: (2022)

A Novel Pyroptosis-Related Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Osteosarcoma
por: Zhang, Yiming, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5sm28av4uuearmbf13dq6bbs4r